Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.94)
# 3,020
Out of 4,876 analysts
209
Total ratings
23.58%
Success rate
-1.99%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.47 | +514.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.94 | +754.70% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.04 | +276.98% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.20 | +81.82% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.83 | +9.59% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.30 | +2,535.91% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.45 | +451.52% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.96 | +971.43% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.25 | +568.15% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.27 | +4,326.88% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.28 | +683.58% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.50 | +301.61% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $6.86 | +337.05% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.55 | +190.30% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.43 | +81,314.28% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.75 | +481.82% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.00 | +500.60% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.50 | +6,588.96% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.04 | +1,630.77% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.14 | +834.58% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.50 | +449,900.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $9.24 | +5,311.26% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $15.32 | +1,466.58% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.94 | +8,409.73% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.87 | +11,460.69% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.97 | +133,903.35% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.55 | +353.07% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.21 | +1,257.47% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.31 | +1,631.60% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.41 | +646.89% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.36 | +111.86% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $2.65 | +54,239.62% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $33.89 | -29.18% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.82 | +187,812.09% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.82 | +1,043,856.04% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.47
Upside: +514.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.94
Upside: +754.70%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.04
Upside: +276.98%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.20
Upside: +81.82%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.83
Upside: +9.59%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.30
Upside: +2,535.91%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.45
Upside: +451.52%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.96
Upside: +971.43%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.25
Upside: +568.15%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.27
Upside: +4,326.88%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +683.58%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.50
Upside: +301.61%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $6.86
Upside: +337.05%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.55
Upside: +190.30%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.43
Upside: +81,314.28%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.75
Upside: +481.82%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.00
Upside: +500.60%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.50
Upside: +6,588.96%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.04
Upside: +1,630.77%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.14
Upside: +834.58%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.50
Upside: +449,900.00%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $9.24
Upside: +5,311.26%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $15.32
Upside: +1,466.58%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.94
Upside: +8,409.73%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.87
Upside: +11,460.69%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.97
Upside: +133,903.35%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.55
Upside: +353.07%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.21
Upside: +1,257.47%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.31
Upside: +1,631.60%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $2.41
Upside: +646.89%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.36
Upside: +111.86%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $2.65
Upside: +54,239.62%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $33.89
Upside: -29.18%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.82
Upside: +187,812.09%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.82
Upside: +1,043,856.04%